WTF Health: Transcarent’s Valuation Soars Past $1B. Hear Why Glen Tullman Says It’s More Than Worth It
Transcarent CEO Glen Tullman sits down with Jessica DaMassa from WTF Health to discuss further details about our Series C funding announcement from existing investors and leading health systems including Northwell Health, Intermountain Healthcare, and Rush University Medical Center and the growing adoption of Transcarent’s new and different approach to managing care for employees and their families along with the strong interest by these innovative health delivery systems to explore new payment models.